ClinicalTrials.gg
CompletedNCT05788354IUDUpdated Mar 28, 2023

Intra-cesarean Post Placental Introducer Withdrawal IUD Insertion Technique

An interventional study of IUD insertion during cesarean section in Intrauterine Contraceptive Device Complication, sponsored by Cairo University. Completed at 2 sites in Egypt. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-28.

Sponsored by Cairo University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Sep 2020, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
788
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This is a prospective randomized controlled study that was conducted to compare between the conventional (manual) technique of post placental IUD insertion and a new technique (intra-cesarean post placental introducer withdrawal IUD insertion technique) for IUD insertion during cesarean section regarding side effects and complications.

Read the detailed description

Complete history taking and clinical examination were obtained from all cases. Lower segment cesarean section though Pfannenstiel incision was performed. Copper T380 IUDs were inserted to all participants during cesarean section after delivery of the placenta using the following techniques:

Group A (control group): (n = 420) First, the investigators Performed time out and verify that there were no contraindications to IUD placement:, Second, after package opening the investigators Removed the IUD from the introducer and trimmed IUD threads to 12 cm, Third, the investigators Grasped the IUD firmly along the stem of the device, Fourth the investigators Stabilized the uterus using the non-dominant hand or with the aid of an assistant and advanced the IUD through the hysterotomy to the fundus, Fifth, the investigators Removed hand and directed the IUD threads into the cervix and finally the investigators Closed the uterine incision, took care not to incorporate the IUD strings.

Group B (study group): (n = 420) First the investigators Performed time out and verified that there were no contraindications to IUD placement, Second, after package opening the investigators Removed IUD from the introducer and trimmed the IUD threads to 12 cm and also trimmed the introducer to 12 cm, Third, the investigators Loaded the IUD again inside the introducer (through the trimmed end) and kept the arms of the IUD unfolded, Forth, the investigators removed the shoulders of the introducer, Fifth, the investigators held the uterus and stabilized it by the non-dominant hand and guided the introducer containing the IUD strings first through the cervix then the investigators advanced the introducer with the IUD arms unfolded to the fundus and kept the IUD their by pressing on the fundus, then the investigators pushed the introducer gently through the cervix to the vagina, Finally, the investigators Closed the uterine incision, took care not to incorporate the introducer or the threads and then the investigators removed the introducer gently manually from the vagina after closure of the skin and ceiling of the wound.

02

Conditions studied

  • Intrauterine Contraceptive Device Complication
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women attending for elective or emergency cesarean section

Exclusion criteria

Exclusion Criteria:

  • upper segment cesarean scar
  • cesarean for placenta previa or placenta accrete
  • evident infections
  • uterine anomalies
  • uterine myomas
  • bleeding tendency.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
788 participants (actual)

Study arms

  • Active comparator
    conventional method

    IFirst, we Performed time out and verify that there were no contraindications to IUD placement:, Second, after package opening we Removed the IUD from the introducer and trimmed IUD threads to 12 cm, Third, we Grasped the IUD firmly along the stem of the device, Fourth we Stabilized the uterus using the non-dominant hand or with the aid of an assistant and advanced the IUD through the hysterotomy to the fundus, Fifth, we Removed hand and directed the IUD threads into the cervix and finally we Closed the uterine incision, took care not to incorporate the IUD strings.

    Procedure: IUD insertion during cesarean section

  • Experimental
    new method

    First we Performed time out and verified that there were no contraindications to IUD placement, Second, after package opening we Removed IUD from the introducer and trimmed the IUD threads to 12 cm and also trimmed the introducer to 12 cm, Third, we Loaded the IUD again inside the introducer (through the trimmed end) and kept the arms of the IUD unfolded, Forth, we removed the shoulders of the introducer, Fifth, we held the uterus and stabilized it by the non-dominant hand and guided the introducer containing the IUD strings first through the cervix then we advanced the introducer with the IUD arms unfolded to the fundus and kept the IUD their by pressing on the fundus, then we pushed the introducer gently through the cervix to the vagina, Finally, we Closed the uterine incision, took care not to incorporate the introducer or the threads and then we removed the introducer gently manually from the vagina after closure of the skin and ceiling of the wound.

    Procedure: IUD insertion during cesarean section

Interventions

  • ProcedureIUD insertion during cesarean section

    placement of IUD during cesarean section after placental delivery

06

What researchers measure

Primary outcomes

  1. Intrauterine displacement of the IUD

    transvaginal ultrasound : the distance from the top of the uterine cavity to the IUD which should be \< 3 mm

    Time frame: 6 months

Secondary outcomes

  1. Missed or non-visualization of IUD threads

    vaginal speculum examination: Missed or non-visualization of IUD threads by vaginal speculum examination

    Time frame: 6 months

  2. Discontinuation of the method

    questionnaire

    Time frame: 6 months

  3. duration of surgery

    time of surgery in minutes

    Time frame: 6 months

07

Study locations

2 sites
  • Cairo University
    Cairo, 2315, Egypt
  • Cairo Univesity
    Cairo, Egypt
08

References and documents

Publications

  • Elsokary A, Elkhyat A, Elshwaikh S. Evaluation of Post-Placental IUD Insertion during Cesarean Section at a Tertiary Care Hospital in Egypt. Open Journal of Obstetrics and Gynecology 2020;10:516-25. https://doi.org/10.4236/ojog.2020.1040046.
  • Seleem M, Sedik MM, Megahed AMM, Nabil H. Conventional manual technique of post placental IUD insertion versus intra-cesarean post placental introducer withdrawal IUD insertion technique: a new standardized technique for IUD insertion during cesarean section: a randomized controlled trial. BMC Pregnancy Childbirth. 2023 Jun 26;23(1):474. doi: 10.1186/s12884-023-05777-1. PubMed 37365489 ↗

Individual participant data

Plan to share: Yes — all the participants data collected during the study after de-identification will be available

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: beginning 1 month after publication for 5 years

Access criteria: through direct email with the principle investigator email: mostafasaleem@kasralainy.edu.eg

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2020 to primary completion in Sep 2021, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2023
First posted
Mar 28, 2023
StartActual
Sep 1, 2020
Primary completionActual
Sep 1, 2021
CompletionActual
Apr 22, 2022
Last update
Mar 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05788354
Lead sponsor
Cairo University
Responsible party
mostafa abdel hamid seleem (professor of 0b&gyn, Cairo University) — Principal investigator
First posted
Mar 28, 2023
Start date
Sep 1, 2020
Primary completion
Sep 1, 2021
Completion
Apr 22, 2022
Last update
Mar 28, 2023

Study contacts

mostafa AH seleem, MD
principal investigator · professor of ob&gyn

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion